Search results
Showing 3466 to 3480 of 8218 results
More detail about Diagnostics Advisory Committee (DAC) registration, meeting arrangements and types of attendee.
Referral points to virtual wards are similar to traditional models of care. Our guidance and advice can help you decide where to provide care and what to consider.
Home Implementing NICE guidance Social care...
We're working with colleagues to ensure that virtual wards are used in a way that maximises the value for patients and the NHS.
This resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
Supporting the health and care system to implement virtual wards
Virtual wards (also known as hospital at home) provide hospital level care at home.
Mapping NICE guidelines to the CQC's single assessment framework
This NICE resource is intended to demonstrate how our guidance can be used in the Care Quality Commission (CQC) assessment process.
The government uses a simple, but effective, model of the causes of health inequalities. This helps guide effective strategies to reduce them.
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
Ask an expert from NICE International, part of the UK's National Institute for Health and Care Excellence, to speak at a healthcare event in your country
Our role in the Innovative Licensing and Access Pathway (ILAP)
The Innovative Licensing and Access Pathway (ILAP) is a unique initiative which works with medicine developers early on to help get new medicines to patients faster.
Home What NICE does Digital health...
Tools for building or evaluating a medtech evidence base with NICE
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
Managed access allows people to access promising new treatments that would otherwise not be recommended because it is too uncertain whether the treatment is cost-effective.